Difference between revisions of "Prednisone (Sterapred)"
Jump to navigation
Jump to search
m |
m |
||
| Line 9: | Line 9: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
| − | <div style="column-count: | + | <div style="column-count:3;-moz-column-count:3;-webkit-column-count:3"> |
*[[Acute promyelocytic leukemia]] | *[[Acute promyelocytic leukemia]] | ||
*[[Adult T-cell leukemia-lymphoma]] | *[[Adult T-cell leukemia-lymphoma]] | ||
| Line 24: | Line 24: | ||
*[[Hodgkin lymphoma, nodular lymphocyte-predominant]] | *[[Hodgkin lymphoma, nodular lymphocyte-predominant]] | ||
*[[Hodgkin lymphoma]] | *[[Hodgkin lymphoma]] | ||
| + | *[[Langerhans cell histiocytosis]] | ||
*[[Large granular lymphocytic leukemia]] | *[[Large granular lymphocytic leukemia]] | ||
*[[Mantle cell lymphoma]] | *[[Mantle cell lymphoma]] | ||
| Line 204: | Line 205: | ||
[[Category:Hodgkin lymphoma, nodular lymphocyte-predominant medications]] | [[Category:Hodgkin lymphoma, nodular lymphocyte-predominant medications]] | ||
[[Category:Immune thrombocytopenic purpura (ITP) medications]] | [[Category:Immune thrombocytopenic purpura (ITP) medications]] | ||
| + | [[Category:Langerhans cell histiocytosis medications]] | ||
[[Category:Large granular lymphocytic leukemia medications]] | [[Category:Large granular lymphocytic leukemia medications]] | ||
[[Category:Mantle cell lymphoma medications]] | [[Category:Mantle cell lymphoma medications]] | ||
Revision as of 20:11, 6 November 2017
General information
Class/mechanism: Corticosteroid, glucocorticoid.[1][2]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Acute promyelocytic leukemia
- Adult T-cell leukemia-lymphoma
- Anaplastic large cell lymphoma
- Autoimmune thrombocytopenic purpura (ITP)
- B-cell acute lymphoblastic leukemia
- Burkitt lymphoma
- Chronic lymphocytic leukemia (CLL/SLL)
- Coagulopathies
- Diffuse large B-cell lymphoma
- Erdheim-Chester disease
- Follicular lymphoma
- HIV-associated lymphoma
- Hodgkin lymphoma, nodular lymphocyte-predominant
- Hodgkin lymphoma
- Langerhans cell histiocytosis
- Large granular lymphocytic leukemia
- Mantle cell lymphoma
- Marginal zone lymphoma
- Mast cell diseases
- Mediastinal gray-zone lymphoma
- Multiple myeloma
- Myelodysplastic syndrome
- Myelofibrosis
- Peripheral T-cell lymphoma
- Primary mediastinal B-cell lymphoma
- Prostate cancer
- T-cell acute lymphoblastic leukemia
- Thymoma
- Transformed lymphoma
- Transplant conditioning regimens
- Waldenström macroglobulinemia
Patient drug information
- Prednisone (Sterapred) patient drug information (Chemocare)[3]
- Prednisone (Sterapred) patient drug information (UpToDate)[4]
Also known as
| Synonyms | |||||||
|---|---|---|---|---|---|---|---|
| APO-Prednisone | APO-Prenisona | APO Prednison | Artinizona | Artrizona | BE-Tabs Prednisone | Becortem | Bersen |
| Colisone | Cortancyl | Corticorten | Cortigen | Cortiol | Cortiprex | Cutason | Dacortin |
| Decortancyl | Decortin | Decortisyl | Dehydrocortison | Delcortin | Dellacorta | Delta-Cortisone | Delta Cortelan |
| Deltacortene | Deltacortone | Deltason | Deltasone | Deltisona | DI Adreson | Dispersona | DLI-Prednisone |
| Drazone | Econosone | Ednaprom | Encorton | Erlanison | Flamacorten | Hostacortin | Ifison |
| Isolone | Liquid Pred | Liquid Prednisone | Lisacort | ME Korti | Meticorten | Nisocortec | Nisona |
| Nisone | Nizon | Nosipren | Novoprednisone | Orasone | Panafcort | Panasol-S | Pehacort |
| Pharmapred | Precortil | Predcort | Predeltin | Predicor | Predicorten | Predinis | Preditec |
| Prednax | Prednicap | Prednicen-M | Prednilonga-Retard | Predniment | Prednison | Prednison-GF | Prednisona |
| Prednisona Alonga | Prednisona GI Brul | Prednison Alpharma | Prednison Amino | Prednisone Acetate | Prednisone Arrow | Prednisone Biogaran | Prednisone COX |
| Prednisone EG | Prednisone G GAM | Prednisone GXI | Prednisone Labatec | Prednisone Organon | Prednison Frederiksberg | Prednison Galen | Prednison Galepharm |
| Prednison Hexal | Prednison Leciva | Prednison Nurison | Prednison Ratiopharm | Prednison Sandoz | Prednison Streuli | Prednisonum | Prednitone |
| Predson | Predsone | Predval | Procion | Prolix | Pronison | Pulmison | Rectodelt |
| Senterlic | SK-Prednisone | Sone | Steerometz | Sterapred | Sterapred DS | Trolic | Ultracorten |
| Vitazon | Winpred | ||||||
References
Categories:
- Drug index
- Oral medications
- Immunosuppressants
- Steroids
- Acute promyelocytic leukemia medications
- Adult T-cell leukemia-lymphoma medications
- Anaplastic large cell lymphoma medications
- B-cell acute lymphoblastic leukemia medications
- Burkitt lymphoma medications
- Chronic lymphocytic leukemia (CLL/SLL) medications
- Coagulopathy medications
- Diffuse large B-cell lymphoma medications
- Erdheim-Chester disease medications
- Follicular lymphoma medications
- HIV-associated lymphoma medications
- Hodgkin lymphoma medications
- Hodgkin lymphoma, nodular lymphocyte-predominant medications
- Immune thrombocytopenic purpura (ITP) medications
- Langerhans cell histiocytosis medications
- Large granular lymphocytic leukemia medications
- Mantle cell lymphoma medications
- Marginal zone lymphoma medications
- Mediastinal gray-zone lymphoma medications
- Multiple myeloma medications
- Myelodysplastic syndrome medications
- Myelofibrosis medications
- Peripheral T-cell lymphoma medications
- Primary mediastinal B-cell lymphoma medications
- Prostate cancer medications
- T-cell acute lymphoblastic leukemia medications
- Thymoma medications
- Transformed lymphoma medications
- Transplant medications
- Waldenström macroglobulinemia medications
- Drugs FDA approved in 1955
- WHO Essential Cancer Medicine